Dr. Raanan Cohen

VP Clinical Development & Strategy at cCAM-Bio, developing new imune check point inhibitor to treat Cancer Business Director - Hospital, Specialty and Oncology products Director – P&L responsibility, building strategy of the company in the areas of HCV, HIV, hospitals products including the build up of the Oncology Unit of Merck in Israel focusing on immunotherapy.

Medical Director - Responsible for Medical Affairs, Regulatory Affairs and Clinical Research affairs, building, setting a vision, a strategy for making clear objectives, developing a new concept in the array content, rebuilding the R&D process.

Clinical Research Director - Responsible for all R&D at the company, built new department position Israel's as one of the best places for clinical research in Merck, plan, manage and assure control for clinical studies phases I -III including oncology FIH studies, close collaboration with hospitals and opinion leaders in various fields of medicine.

Medical Director in a Start Up company - international marketing support – business development to identify new markets, building a marketing strategy in the areas of digital medicine.

Establishment of the OncoNet Israel - a network of 18 top medical centers to lead Mercks pipeline development, managed to include Sheba Medical Center in that network, building Phase I unit for those studies which allowed Sheba get massive investments and research in the field of cancer.

Built strategic collaboration between Merck HQ and one of the big Sick funds to create a world's leading research center in the field of Real World Evidence with massive investment.

CTrials NGO Chairman - acting together with the Ministries of Finance, Health and Industry, Medical Association, researchers to promote clinical research in Israel.